Neurocrine Biosciences NBIX Income Statement (2010-2026)

NASDAQ NBIX
$153.72 -1.41 (-0.91%)
As of: Sep 9, 2026 · 1:46 PM EDT
Reported Financials

Neurocrine Biosciences Quarterly Income Statement

Periods 65 quarters
Latest Jun 2026

Neurocrine Biosciences reported revenue of $959.00M and net income of $149.10M for the quarter ended Jun 2026, up 39.5% year over year. This income statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
296.00M312.00M310.60M378.20M387.90M412.00M420.40M452.70M498.80M515.20M515.30M590.20M622.10M627.70M572.60M687.50M794.90M805.50M814.50M959.00M
Cost of RevenueCost of Rev
4.20M4.10M4.60M4.80M6.10M7.70M8.50M11.50M11.20M8.50M7.50M9.20M8.00M9.30M9.20M10.30M14.00M17.60M13.80M23.20M
Gross Profit
291.80M307.90M306.00M373.40M381.80M404.30M411.90M441.20M487.60M506.70M507.80M581.00M614.10M618.40M563.40M677.20M780.90M787.90M800.70M935.80M
Operating items
Amortization - Intangibles
1.00M16.40M
Research & DevelopmentR&D
92.70M87.40M102.20M135.90M107.70M118.00M139.50M145.80M142.20M137.50M159.40M191.10M195.00M185.60M263.20M244.30M250.00M258.20M296.20M326.70M
Selling, General & AdministrativeSG&A
154.60M156.50M200.70M182.80M186.30M182.90M242.70M221.80M204.20M218.90M243.10M242.00M234.30M287.80M276.50M286.30M291.60M301.80M318.50M439.70M
Other Operating ExpensesOther Opex
4.20M104.40M4.60M4.80M6.10M7.70M152.40M11.50M11.20M8.50M13.50M11.70M9.00M12.30M14.30M34.60M28.60M
Operating ExpensesOpex
251.50M348.30M307.50M323.50M300.10M308.60M534.60M379.10M357.60M364.90M416.00M444.80M438.30M485.70M549.00M541.90M555.90M594.60M621.10M807.50M
Operating IncomeOp. Inc
44.50M-36.30M3.10M54.70M87.80M103.40M-114.20M73.60M141.20M150.30M99.30M145.40M183.80M142.00M23.60M145.60M239.00M210.90M193.40M151.50M
EBIT
44.50M-36.30M3.10M54.70M87.80M103.40M-114.20M73.60M141.20M150.30M99.30M145.40M183.80M142.00M23.60M145.60M239.00M210.90M193.40M151.50M
Non-operating items
Non Operating Interest Expenses
6.60M6.60M2.60M2.20M1.20M1.10M1.10M1.30M1.10M1.10M1.10M2.90M
Interest & Investment IncomeInt & Inv Inc
0.80M0.70M1.00M1.60M0.20M1.30M9.80M10.70M14.50M18.90M22.30M22.80M23.40M22.50M21.70M20.60M22.20M25.80M28.10M12.40M
Other Non Operating IncomeOther Non Op Inc.
-70.00M
Non Operating IncomeNon Op. Inc.
-14.00M22.50M18.30M-78.00M10.10M14.50M10.90M48.00M-25.60M47.90M-64.80M-46.80M6.50M20.60M-8.90M13.90M52.80M28.50M53.40M10.70M
Net income details
EBT
30.50M-13.80M21.40M-23.30M97.90M117.90M-103.30M121.60M115.60M198.20M34.50M98.60M190.30M162.60M14.70M159.50M291.80M239.40M246.80M162.20M
Tax ProvisionsTaxes
8.00M-6.50M7.50M-6.40M29.40M28.90M-26.70M26.10M32.50M50.50M-8.90M33.60M60.50M59.50M6.80M52.00M82.30M85.70M48.90M17.80M
Profit After TaxPAT
22.50M-7.30M13.90M-19.80M68.50M89.00M-76.60M97.10M83.10M156.40M43.40M65.00M141.80M95.60M11.10M111.00M210.20M153.60M197.90M149.10M
Income from Continuing OperationsIncome (Continuing)
22.50M-7.30M13.90M-16.90M68.50M89.00M-76.60M95.50M83.10M147.70M43.40M65.00M129.80M103.10M7.90M107.50M209.50M153.70M197.90M144.40M
Consolidated Net IncomeConsol Net Inc.
22.50M-7.30M13.90M-16.90M68.50M89.00M-76.60M95.50M83.10M147.70M43.40M65.00M129.80M103.10M7.90M107.50M209.50M153.70M197.90M144.40M
Income towards Parent CompanyParent Net Inc
22.50M-7.30M13.90M-16.90M68.50M89.00M-76.60M95.50M83.10M147.70M43.40M65.00M129.80M103.10M7.90M107.50M209.50M153.70M197.90M144.40M
Net Income towards Common StockholdersNet Income
22.50M-7.30M13.90M-16.90M68.50M89.00M-76.60M95.50M83.10M147.70M43.40M65.00M129.80M103.10M7.90M107.50M209.50M153.70M197.90M144.40M
Additional items
EPS (Basic)
0.24-0.080.15-0.180.720.93-0.790.980.851.510.430.641.281.030.081.092.111.541.971.43
EPS (Diluted)
0.23-0.070.14-0.180.690.90-0.790.950.821.460.420.631.240.990.081.062.041.501.911.39
Shares Outstanding
94.70M94.60M95.30M95.60M95.80M95.80M97.10M97.60M97.90M97.70M99.80M100.80M101.10M100.40M99.70M99.00M99.40M99.50M100.50M101.00M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
97.70M97.90M97.60M95.60M99.00M98.90M97.10M100.20M101.10M101.00M103.60M103.90M104.30M103.70M102.50M101.00M102.50M102.50M103.40M104.20M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
94.80M94.90M95.50M95.60M96.10M96.50M97.50M97.60M98.20M98.70M100.60M100.90M101.20M99.40M99.00M99.00M99.70M100.10M100.60M101.60M
EBITDA
44.50M-36.30M3.10M54.70M87.80M103.40M-114.20M73.60M141.20M150.30M99.30M145.40M183.80M142.00M23.60M145.60M239.00M210.90M193.40M151.50M
Interest ExpensesInt Expense
6.60M6.60M2.60M2.20M1.20M1.10M1.10M1.30M1.10M1.10M1.10M2.90M
Tax Rate
26.23%47.10%35.05%27.47%30.03%24.51%25.85%21.46%28.11%25.48%-25.80%34.08%31.79%36.59%46.26%32.60%28.20%35.80%19.81%10.97%